anti human ccl22 neutralizing antibody (R&D Systems)
R&D Systems is a verified supplier 
R&D Systems manufactures this product 
93
Structured Review
R&D Systems
anti human ccl22 neutralizing antibody
Anti Human Ccl22 Neutralizing Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 12 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+ccl22+antibody/Human+CCL22%2FMDC+Antibody/pm42815071-107-31-35
Average 93 stars, based on 12 article reviews
Anti Human Ccl22 Neutralizing Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 12 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+ccl22+antibody/Human+CCL22%2FMDC+Antibody/pm42815071-107-31-35
Average 93 stars, based on 12 article reviews
anti human ccl22 neutralizing antibody - by Bioz Stars,
2026-10
93/100 stars
Images
Related Articles
Injection:Article Title: Aflatoxin B1 and Epstein-Barr virus-induced CCL22 expression stimulates B cell infection. Article Snippet: .. Briefly, CCL22 function was neutralized by treating the mice with a neutralizing Article Title: TRAIL agonists rescue mice from radiation-induced lung, skin, or esophageal injury Article Snippet: .. Seven-week-old Trail –/– female mice received a single thoracic x-ray irradiation dose of 20 Gy with shielding of other organs and were treated with either 20 μg of Article Title: TRAIL agonists rescue mice from radiation-induced lung, skin or esophageal injury Article Snippet: .. 7 week old Trail-/- female mice received a single thoracic x-ray irradiation dose of 20-Gy with shielding of other organs and were either treated with 20 μg of Irradiation:Article Title: TRAIL agonists rescue mice from radiation-induced lung, skin, or esophageal injury Article Snippet: .. Seven-week-old Trail –/– female mice received a single thoracic x-ray irradiation dose of 20 Gy with shielding of other organs and were treated with either 20 μg of Article Title: TRAIL agonists rescue mice from radiation-induced lung, skin or esophageal injury Article Snippet: .. 7 week old Trail-/- female mice received a single thoracic x-ray irradiation dose of 20-Gy with shielding of other organs and were either treated with 20 μg of Sterility:Article Title: TRAIL agonists rescue mice from radiation-induced lung, skin, or esophageal injury Article Snippet: .. Seven-week-old Trail –/– female mice received a single thoracic x-ray irradiation dose of 20 Gy with shielding of other organs and were treated with either 20 μg of Article Title: TRAIL agonists rescue mice from radiation-induced lung, skin or esophageal injury Article Snippet: .. 7 week old Trail-/- female mice received a single thoracic x-ray irradiation dose of 20-Gy with shielding of other organs and were either treated with 20 μg of Saline:Article Title: TRAIL agonists rescue mice from radiation-induced lung, skin, or esophageal injury Article Snippet: .. Seven-week-old Trail –/– female mice received a single thoracic x-ray irradiation dose of 20 Gy with shielding of other organs and were treated with either 20 μg of Article Title: TRAIL agonists rescue mice from radiation-induced lung, skin or esophageal injury Article Snippet: .. 7 week old Trail-/- female mice received a single thoracic x-ray irradiation dose of 20-Gy with shielding of other organs and were either treated with 20 μg of Recombinant:Article Title: H3K18 lactylation in cancer-associated fibroblasts drives malignant pleural effusion progression via TNFR2 + T reg recruitment Article Snippet: .. In specific experimental conditions, the following reagents were added to the lower chamber: anti-CCL17 antibody (50 ng/ml, #MAB364-SP, R&D Systems), anti-CCL20 antibody (50 ng/ml, #MAB360-SP, R&D Systems), Article Title: H3K18 lactylation in cancer-associated fibroblasts drives malignant pleural effusion progression via TNFR2 + T reg recruitment. Article Snippet: .. In specific experimental conditions, the following reagents were added to the lower chamber: anti-CCL17 antibody (50 ng/ml, #MAB364-SP, R&D Systems), antiCCL20 antibody (50 ng/ml, #MAB360-SP, R&D Systems), Neutralization:Article Title: PGE 2 -EP2/EP4 signaling elicits immunosuppression by driving the mregDC-Treg axis in inflammatory tumor microenvironment. Article Snippet: For CD8 T cells depletion in WTmice treated with vehicle or EP2 KOmice treated EP4 antagonists, IgG2b isotype (Clone: LTF-2, BioXCell) or anti-CD8a antibody (Clone: 2.43, BioXCell) were injected intraperitoneally at days 1, 0, 3 at the dose of 100 mg, and thereafter at days 7 and 14 at the dose of 200 mg. .. For Ccl17 and Ccl22 neutralization in vivo, anti-Ccl17 antibody and In Vivo:Article Title: PGE 2 -EP2/EP4 signaling elicits immunosuppression by driving the mregDC-Treg axis in inflammatory tumor microenvironment. Article Snippet: For CD8 T cells depletion in WTmice treated with vehicle or EP2 KOmice treated EP4 antagonists, IgG2b isotype (Clone: LTF-2, BioXCell) or anti-CD8a antibody (Clone: 2.43, BioXCell) were injected intraperitoneally at days 1, 0, 3 at the dose of 100 mg, and thereafter at days 7 and 14 at the dose of 200 mg. .. For Ccl17 and Ccl22 neutralization in vivo, anti-Ccl17 antibody and Transplantation Assay:Article Title: PGE 2 -EP2/EP4 signaling elicits immunosuppression by driving the mregDC-Treg axis in inflammatory tumor microenvironment. Article Snippet: For CD8 T cells depletion in WTmice treated with vehicle or EP2 KOmice treated EP4 antagonists, IgG2b isotype (Clone: LTF-2, BioXCell) or anti-CD8a antibody (Clone: 2.43, BioXCell) were injected intraperitoneally at days 1, 0, 3 at the dose of 100 mg, and thereafter at days 7 and 14 at the dose of 200 mg. .. For Ccl17 and Ccl22 neutralization in vivo, anti-Ccl17 antibody and Isolation:Article Title: Prolactin enhances T regulatory cell promotion of breast cancer through the long form prolactin receptor Article Snippet: .. Ten million splenocytes, isolated from Foxp3 + EGFP Balb/c mice were placed in the upper chamber (5 μm pore size, Corning 3421) and 1 mL conditioned medium from 4T1 cells with or without prolactin treatment was added to the lower chamber in the presence or absence of 1 μg/mL mouse anti-CCL17 or Pore Size:Article Title: Prolactin enhances T regulatory cell promotion of breast cancer through the long form prolactin receptor Article Snippet: .. Ten million splenocytes, isolated from Foxp3 + EGFP Balb/c mice were placed in the upper chamber (5 μm pore size, Corning 3421) and 1 mL conditioned medium from 4T1 cells with or without prolactin treatment was added to the lower chamber in the presence or absence of 1 μg/mL mouse anti-CCL17 or |
